Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carotenoid Status and Psychological Impact of Presymptomatic Macular Degeneration Genetic Risk Assessment: The MAGENTA Randomized Trial.

Ophthalmology science·2026
Same author

Retinal Carotenoid Supplementation Increases HDL Cholesterol in Humans and Mice.

Life (Basel, Switzerland)·2026
Same author

Mechanism of Lutein to <i>meso</i>-Zeaxanthin Isomerization by RPE65 Catalysis.

bioRxiv : the preprint server for biology·2025
Same author

Delayed-onset <i>Moraxella nonliquefaciens</i> endophthalmitis following intravitreal injection.

American journal of ophthalmology case reports·2025
Same author

Natural History of Microperimetry and Optical Coherence Tomography in USH2A-Retinopathy: A Structure-Function Association Study.

American journal of ophthalmology·2025
Same author

Assessment of Skin Carotenoids among School Children.

Journal of Nepal Health Research Council·2025
Same journal

Probe-assisted ILM-Rhexis: A Novel Peeling Technique.

Journal of ophthalmic & vision research·2026
Same journal

Full-thickness Macular Hole Formation and Spontaneous Closure Following Vitrectomy Surgery: A Case Report and Review of the Literature.

Journal of ophthalmic & vision research·2026
Same journal

Anterior Segment Eye Diseases and Quality of Life: An Updated Comprehensive Narrative Review.

Journal of ophthalmic & vision research·2026
Same journal

Quality of Life in Patients with Posterior Segment Eye Diseases.

Journal of ophthalmic & vision research·2026
Same journal

Emerging Roles of Regulated Cell Death-mediated Inflammation in Pathophysiology of Ocular Diseases.

Journal of ophthalmic & vision research·2026
Same journal

Early Diagnosis of Glaucoma By Optical Coherence Tomography: A Systematic Review and Network Meta-analysis.

Journal of ophthalmic & vision research·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.9K

Optogenetics for retinal disorders.

Bradley S Henriksen1, Robert E Marc1, Paul S Bernstein1

  • 1Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Journal of Ophthalmic & Vision Research
|February 11, 2015
PubMed
Summary
This summary is machine-generated.

Optogenetics uses light-sensitive opsins to restore vision in diseases like retinitis pigmentosa (RP). Challenges remain in opsin sensitivity, viral delivery, and targeting cells affected by retinal remodeling.

Keywords:
OpsinsOptogeneticsRetinitis Pigmentosa

More Related Videos

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog
09:29

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog

Published on: October 13, 2023

2.4K
Transfection of Mouse Retinal Ganglion Cells by in vivo Electroporation
05:26

Transfection of Mouse Retinal Ganglion Cells by in vivo Electroporation

Published on: April 17, 2011

16.2K

Related Experiment Videos

Last Updated: Apr 17, 2026

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.9K
Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog
09:29

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog

Published on: October 13, 2023

2.4K
Transfection of Mouse Retinal Ganglion Cells by in vivo Electroporation
05:26

Transfection of Mouse Retinal Ganglion Cells by in vivo Electroporation

Published on: April 17, 2011

16.2K

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Biotechnology

Background:

  • Optogenetics offers a promising approach to restore visual function in blinding diseases such as retinitis pigmentosa (RP).
  • This therapy relies on light-sensitive proteins called opsins to control neuronal activity.
  • Successful implementation requires precise targeting of opsin genes to specific retinal cells.

Purpose of the Study:

  • To review the current state and challenges of optogenetic therapy for vision restoration.
  • To highlight advancements in opsin engineering and viral delivery methods.
  • To discuss the impact of retinal remodeling on therapeutic targeting and outcomes.

Main Methods:

  • Utilizes genetic engineering to introduce light-sensitive opsins into retinal cells.
  • Employs viral vectors, primarily adeno-associated virus (AAV), for gene delivery.
  • Investigates different injection routes (intravitreal and subretinal) for targeting specific retinal layers.

Main Results:

  • Viral delivery methods have shown success in preclinical models for targeting inner and outer retinal cells.
  • Current opsins exhibit limited sensitivity to physiological light levels, posing a bioengineering challenge.
  • Neural and glial remodeling in advanced RP complicates cellular target selection and therapeutic efficacy.

Conclusions:

  • Optogenetic therapy holds significant potential for treating blindness, particularly RP.
  • Overcoming challenges in opsin sensitivity, viral delivery in primates, and precise cellular targeting is crucial.
  • Future advancements must address neural remodeling to ensure functional visual restoration.